Eventide Asset Management – GW PHARMACEUTICALS plc ADR

Eventide Asset Management ownership history of GW PHARMACEUTICALS plc ADR
QuarterValueSharesWeighting
Q4 2020$23,774
-44.0%
206,000
-52.8%
0.36%
-56.1%
Q3 2020$42,445
-20.7%
436,0000.0%0.83%
-28.5%
Q2 2020$53,506
40.1%
436,0000.0%1.16%
-5.9%
Q1 2020$38,181
-16.2%
436,0000.0%1.24%
-3.8%
Q4 2019$45,588
126.5%
436,000
149.1%
1.28%
93.2%
Q3 2019$20,130
-33.3%
175,0000.0%0.66%
-27.5%
Q2 2019$30,168
92.4%
175,000
88.2%
0.92%
70.1%
Q1 2019$15,678
153.5%
93,006
46.5%
0.54%
96.7%
Q4 2018$6,184
-43.6%
63,5000.0%0.27%
-32.0%
Q3 2018$10,969
23.8%
63,5000.0%0.40%
9.5%
Q2 2018$8,861
23.8%
63,5000.0%0.37%
9.9%
Q1 2018$7,155
-14.6%
63,5000.0%0.34%
-23.3%
Q4 2017$8,383
30.1%
63,5000.0%0.44%
19.7%
Q3 2017$6,445
1.2%
63,5000.0%0.36%
-7.8%
Q2 2017$6,366
-17.1%
63,5000.0%0.40%
-22.0%
Q1 2017$7,680
8.2%
63,5000.0%0.51%
10.0%
Q4 2016$7,096
-15.8%
63,5000.0%0.46%
-10.3%
Q3 2016$8,428
25.2%
63,500
-13.6%
0.52%
25.0%
Q2 2016$6,730
26.9%
73,5000.0%0.41%
39.2%
Q1 2016$5,303
3.9%
73,5000.0%0.30%
16.1%
Q4 2015$5,104
-18.7%
73,500
7.0%
0.26%
-30.1%
Q3 2015$6,277
41.5%
68,700
90.3%
0.36%
52.1%
Q2 2015$4,435
45.3%
36,100
7.8%
0.24%
4.3%
Q1 2015$3,053
80.4%
33,500
34.0%
0.23%
24.3%
Q4 2014$1,692
-16.3%
25,0000.0%0.18%
-34.4%
Q3 2014$2,021
-24.6%
25,0000.0%0.28%
-22.7%
Q2 2014$2,68225,0000.36%